Privium Fund Management
AXSM icon

Privium Fund Management’s Axsome Therapeutics AXSM Stock Holding History

Privium Fund Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.92M Buy
42,944
+3,000
+8% +$653K 1.54% 19
2026
Q2 		$9.8M Sell
39,944
-18,785
-32% -$4.07M 1.8% 20
2026
Q1 		$9.9M Buy
58,729
+1,851
+3% +$320K 2.07% 15
2025
Q4 		$10.4M Buy
56,878
+4,146
+8% +$579K 1.91% 17
2025
Q3 		$6.4M Hold
52,732
– – 1.15% 17
2025
Q2 		$5.43M Hold
52,732
– – 1.17% 14
2025
Q1 		$6.15M Sell
52,732
-9,500
-15% -$1.08M 1.6% 14
2024
Q4 		$5.27M Sell
62,232
-18,000
-22% -$1.66M 1.19% 18
2024
Q3 		$7.21M Buy
80,232
+5,900
+8% +$515K 1.79% 16
2024
Q2 		$5.87M Sell
74,332
-7,700
-9% -$570K 1.5% 20
2024
Q1 		$6.55M Buy
82,032
+10,000
+14% +$839K 1.75% 17
2023
Q4 		$5.55M Hold
72,032
– – 1.55% 22
2023
Q3 		$5.03M Hold
72,032
– – 1.5% 20
2023
Q2 		$5.27M Sell
72,032
-87,442
-55% -$6.45M 1.52% 19
2023
Q1 		$9.8M Buy
+159,474
New +$10.5M 3.3% 8

Other funds holding AXSM

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
HB Wealth Management
HB Wealth Management Atlanta, Georgia $19.5B AUM 16.96% 1-Year Est. Return
Iridian Asset Management
Iridian Asset Management Westport, Connecticut $275M AUM 37.66% 1-Year Est. Return
Baldwin Wealth Partners
Baldwin Wealth Partners Marion, Massachusetts $1.52B AUM 21.45% 1-Year Est. Return
Washington Trust Advisors
Washington Trust Advisors Wellesley, Massachusetts $1.4B AUM 26.88% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Privium Fund Management's AXSM Position: Q3 2026 in Review

Privium Fund Management increased its Axsome Therapeutics (AXSM) stake by 7.5% in Q3 2026, buying an estimated $653K and bringing the position to 42,944 shares worth $7.92M. The position accounts for 1.54% of the portfolio, ranked #19.

Privium Fund Management first reported a position in AXSM in Q1 2023 and has held it in 15 quarters since. The position peaked at $10.4M in Q4 2025. 133 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • Privium Fund Management held 42,944 shares of Axsome Therapeutics worth $7.92M as of Q3 2026.
  • Privium Fund Management bought 3,000 Axsome Therapeutics shares in Q3 2026, an estimated $653K.
  • Axsome Therapeutics made up 1.54% of Privium Fund Management's portfolio in Q3 2026, its #19 holding.
  • Privium Fund Management first reported a position in Axsome Therapeutics in Q1 2023 and has held it in 15 quarters since.
  • Privium Fund Management's Axsome Therapeutics position peaked at $10.4M in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on Privium Fund Management's 13F filing for Q3 2026, filed 3 Nov 2026.